These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27706392)

  • 1. [Control of potential risk in blood establishments in Brazil: a strategy for regulating authorities].
    Júnior JB; Rattner D; Martins RC
    Rev Panam Salud Publica; 2016 Aug; 40(1):1-8. PubMed ID: 27706392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sanitary regulation as part of health policy in Brazil: gaps and challenges].
    Maia C; Guilhem D
    Rev Panam Salud Publica; 2016 May; 39(5):226-231. PubMed ID: 27706402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The information on a sanitary-and-epidemiologic condition of general educational establishments and catering services of schoolboys].
    Onishchenko GG
    Vopr Pitan; 2008; 77(2):4-9. PubMed ID: 18505093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Facilitating factors and difficulties in the the implementation of sanitary surveillance of drugstores in Salvador, state of Bahia, Brazil].
    Bastos AA; Costa EA; de Castro LL
    Cien Saude Colet; 2011 Sep; 16(9):3863-72. PubMed ID: 21987329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of uncertainty regarding the results of screening immunoassays in blood establishments.
    Pereira P; Westgard JO; Encarnação P; Seghatchian J; de Sousa G
    Transfus Apher Sci; 2015 Apr; 52(2):252-5. PubMed ID: 25754470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Report on the activity of the blood bank accreditation program (1987-1995)].
    Pinto V; Algora M; Blanco L; Carpio N; Cortés A; Muñiz E; Oyonarte S; Puig L; Rodríguez J; Vesga MA
    Sangre (Barc); 1998 Jun; 43(3):196-201. PubMed ID: 9741225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What is the use of hemovigilance?].
    Quaranta JF; Canivet N
    Transfus Clin Biol; 1998 Dec; 5(6):415-21. PubMed ID: 9894333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Governance in the European union: the European Blood Directive as an evolving practice.
    Hansen-Magnusson H
    Clin Lab Med; 2010 Jun; 30(2):489-97. PubMed ID: 20513566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Protagonism of the Brazilian Health Regulatory System in the Evolution of Patient Safety in the Country: History, Dilemmas, and Current Challenges.
    Santana HT; Costa MMM; Nogueira MDSP; Dos Santos ACRB; Carvalho AA; Morelo LT; Ribeiro CFM; de Sousa FC; de Moura HLCA; Barros LS; de Oliveira LSC; Gonçalves MRS
    J Patient Saf; 2020 Dec; 16(4):e260-e266. PubMed ID: 32084092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality management in European screening laboratories in blood establishments: A view of current approaches and trends.
    Pereira P; Westgard JO; Encarnação P; Seghatchian J; de Sousa G
    Transfus Apher Sci; 2015 Apr; 52(2):245-51. PubMed ID: 25765135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy to improve malaria surveillance system preventing transfusion-transmitted malaria in blood banks using molecular diagnostic.
    Batista-Dos-Santos SA; Freitas DRC; Raiol M; Cabral GF; Feio AC; Póvoa MM; Cunha MG; Ribeiro-Dos-Santos Â
    Malar J; 2018 Oct; 17(1):344. PubMed ID: 30285750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The French haemovigilance system.
    Debeir J; Noel L; Aullen J; Frette C; Sari F; Mai MP; Cosson A
    Vox Sang; 1999; 77(2):77-81. PubMed ID: 10516551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood regulation in Brazil: contextualization for improvement].
    Silva Júnior JB; Costa Cda S; Baccara JP
    Rev Panam Salud Publica; 2015 Oct; 38(4):333-8. PubMed ID: 26758225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of blood bank practices in Karachi, Pakistan, and the government's response.
    Luby S; Khanani R; Zia M; Vellani Z; Ali M; Qureshi AH; Khan AJ; Abdul Mujeeb S; Shah SA; Fisher-Hoch S
    Health Policy Plan; 2000 Jun; 15(2):217-22. PubMed ID: 10837045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood supply safety in Afghanistan: a national assessment of high-volume facilities.
    Mansoor GF; Rahmani AM; Kakar MA; Hashimy P; Abrahimi P; Scott PT; Peel SA; Rentas FJ; Todd CS
    Transfusion; 2013 Sep; 53(9):2061-8. PubMed ID: 23216410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 May; 80(99):29841-906. PubMed ID: 26003966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scheme for the selection of measurement uncertainty models in blood establishments' screening immunoassays.
    Pereira P; Westgard JO; Encarnação P; Seghatchian J; de Sousa G
    Transfus Apher Sci; 2015 Feb; 52(1):42-7. PubMed ID: 25620757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.